FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Dieter Schrenk

Research Profile

Living Beings

Anatomy

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Gergely Morten Solecki; Isabel Anna Maria Groh; Carolin Haushofer; Julia Kajzar; Anne Scherhag; Dieter Schrenk; Melanie Esselen
Genotoxic properties of cyclopentenone prostaglandins and the onset of glutathione depletion.
Alexander T Cartus; Wolfram Engst; Hansruedi Glatt; Kristin Herrmann; Karl-Heinz Merz; Lucas W Weishaupt; Dieter Schrenk
Metabolism of methyleugenol in liver microsomes and primary hepatocytes: pattern of metabolites, cytotoxicity, and DNA-adduct formation.
Isabel Anna Maria Groh; Alexander Thomas Cartus; Julia Kajzar; Karl-Heinz Merz; Dieter Schrenk; Sabrina Vallicotti; Melanie Esselen
Genotoxic potential of methyleugenol and selected methyleugenol metabolites in cultured Chinese hamster V79 cells.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Dieter Schrenk (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Gergely Morten Solecki; Isabel Anna Maria Groh; Carolin Haushofer; Julia Kajzar; Anne Scherhag; Dieter Schrenk; Melanie Esselen
Genotoxic properties of cyclopentenone prostaglandins and the onset of glutathione depletion.
Chemical research in toxicology 2013;26(2):252-61.
2012: Alexander T Cartus; Wolfram Engst; Hansruedi Glatt; Kristin Herrmann; Karl-Heinz Merz; Lucas W Weishaupt; Dieter Schrenk
Metabolism of methyleugenol in liver microsomes and primary hepatocytes: pattern of metabolites, cytotoxicity, and DNA-adduct formation.
Toxicological sciences : an official journal of the Society of Toxicology 2012;129(1):21-34.
2012: Isabel Anna Maria Groh; Alexander Thomas Cartus; Julia Kajzar; Karl-Heinz Merz; Dieter Schrenk; Sabrina Vallicotti; Melanie Esselen
Genotoxic potential of methyleugenol and selected methyleugenol metabolites in cultured Chinese hamster V79 cells.
Food & function 2012;3(4):428-36.
2012: Helena Ufelmann; Thomas Krüger; Bernd Luckas; Dieter Schrenk
Human and rat hepatocyte toxicity and protein phosphatase 1 and 2A inhibitory activity of naturally occurring desmethyl-microcystins and nodularins.
Toxicology 2012;293(1-3):59-67.
2012: Anastasia Messer; Nicole Raquet; Christian Lohr; Dieter Schrenk
Major furocoumarins in grapefruit juice II: phototoxicity, photogenotoxicity, and inhibitory potency vs. cytochrome P450 3A4 activity.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2012;50(3-4):756-60.
2011: Anastasia Messer; Anna Nieborowski; Christian Lohr; Christian Strasser; Dieter Schrenk
Major furocoumarins in grapefruit juice I: levels and urinary metabolite(s).
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2011;49(12):3224-31.
2011: Kathrin Kahle; Tanja Kautenburger; Michael Kempf; Matthias Ackermann; Dorothée Hecker; Wolfgang Huemmer; Wolfgang Scheppach; Peter Schreier; Dieter Schrenk; Elke Richling
Intestinal transit and systemic metabolism of apple polyphenols.
European journal of nutrition 2011;50(7):507-22.
2011: Alexander T Cartus; Karl-Heinz Merz; Dieter Schrenk
Metabolism of methylisoeugenol in liver microsomes of human, rat, and bovine origin.
Drug metabolism and disposition: the biological fate of chemicals 2011;39(9):1727-33.
2011: Dieter Schrenk
[Toxicological evaluation and delineation. Food - nutritional supplements - pharmaceuticals].
Pharmazie in unserer Zeit 2011;40(4):316-24.
2011: Robert Roos; Satu Sankari; Hans-Joachim Schmitz; Leo T M van der Ven; Matti Viluksela; Emma Westerholm; Patrik L Andersson; Helen Håkansson; Krister Halldin; Timo Hamers; Gerd Hamscher; Päivi Heikkinen; Merja Korkalainen; Heather A Leslie; Marjo Niittynen; Dieter Schrenk
Hepatic effects of a highly purified 2,2',3,4,4',5,5'-heptachlorbiphenyl (PCB 180) in male and female rats.
Toxicology 2011;284(1-3):42-53.
2011: Sabine Guth; Michael Habermeyer; Dieter Schrenk; Gerhard Eisenbrand
Update of the toxicological assessment of furanocoumarins in foodstuffs (Update of the SKLM statement of 23/24 September 2004)--Opinion of the Senate Commission on Food Safety (SKLM) of the German Research Foundation (DFG).
Molecular nutrition & food research 2011;55(5):807-10.
2011: Martin Chopra; Dieter Schrenk
Dioxin toxicity, aryl hydrocarbon receptor signaling, and apoptosis-persistent pollutants affect programmed cell death.
Critical reviews in toxicology 2011;41(4):292-320.
2011: Bülent Soyalan; Jutta Minn; Hans J Schmitz; Dieter Schrenk; Frank Will; Helmut Dietrich; Matthias Baum; Gerhard Eisenbrand; Christine Janzowski
Apple juice intervention modulates expression of ARE-dependent genes in rat colon and liver.
European journal of nutrition 2011;50(2):135-43.
2010: Yvonne Fery; Stefan O Mueller; Dieter Schrenk
Development of stably transfected human and rat hepatoma cell lines for the species-specific assessment of xenobiotic response enhancer module (XREM)-dependent induction of drug metabolism.
Toxicology 2010;277(1-3):11-9.
2010: Angela Mally; Carmen Graff; Olga Schmal; Sabrina Moro; Carolin Hamberger; Ute M D Schauer; Jens Brück; Sibel Ozden; Max Sieber; Ulrich Steger; Dieter Schrenk; Gordon C Hard; James Kevin Chipman; Wolfgang Dekant
Functional and proliferative effects of repeated low-dose oral administration of furan in rat liver.
Molecular nutrition & food research 2010;54(11):1556-67.
2010: Aline Bach; Julia Bender-Sigel; Dieter Schrenk; Daniela Flügel; Thomas Kietzmann
The antioxidant quercetin inhibits cellular proliferation via HIF-1-dependent induction of p21WAF.
Antioxidants & redox signaling 2010;13(4):437-48.
2010: Martin Chopra; Maike Gährs; Melina Haben; Christine Michels; Dieter Schrenk
Inhibition of apoptosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin depends on protein biosynthesis.
Cell biology and toxicology 2010;26(4):391-401.
2010: Martin Chopra; Pascal Link; Christine Michels; Dieter Schrenk
Characterization of ochratoxin A-induced apoptosis in primary rat hepatocytes.
Cell biology and toxicology 2010;26(3):239-54.
2010: Christian Lohr; Nicole Raquet; Dieter Schrenk
Application of the concept of relative photomutagenic potencies to selected furocoumarins in V79 cells.
Toxicology in vitro : an international journal published in association with BIBRA 2010;24(2):558-66.
2010: E Gorgus; Christian Lohr; N Raquet; S Guth; Dieter Schrenk
Limettin and furocoumarins in beverages containing citrus juices or extracts.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2010;48(1):93-8.
2009: Dieter Schrenk
Dietary fiber, low-molecular-weight food constituents and colo-rectal inflammation in animal models -- a review.
Molecular nutrition & food research 2009;53(10):1281-8.
2009: Yvonne Fery; Inga Buschauer; Christian Salzig; Patrick Lang; Dieter Schrenk
Technical pentabromodiphenyl ether and hexabromocyclododecane as activators of the pregnane-X-receptor (PXR).
Toxicology 2009;264(1-2):45-51.
2009: Nicole Raquet; Dieter Schrenk
Relative photomutagenicity of furocoumarins and limettin in the hypoxanthine phosphoribosyl transferase assay in V79 cells.
Chemical research in toxicology 2009;22(9):1639-47.
2009: Martin Chopra; Arunasalam M Dharmarajan; Gregor Meiss; Dieter Schrenk
Inhibition of UV-C light-induced apoptosis in liver cells by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Toxicological sciences : an official journal of the Society of Toxicology 2009;111(1):49-63.
2008: Markus Waldecker; Tanja Kautenburger; Heike Daumann; Cordula Busch; Dieter Schrenk
Inhibition of histone-deacetylase activity by short-chain fatty acids and some polyphenol metabolites formed in the colon.
The Journal of nutritional biochemistry 2008;19(9):587-93.
2008: Leo T M van der Ven; Ton van de Kuil; P E G Leonards; Wout Slob; Rocío F Cantón; Silke Germer; Theo J Visser; Sabina Litens; Helen Håkansson; Dieter Schrenk; Martin van den Berg; Aldert H Piersma; Joseph G Vos; Antoon Opperhuizen
A 28-day oral dose toxicity study in Wistar rats enhanced to detect endocrine effects of decabromodiphenyl ether (decaBDE).
Toxicology letters 2008;179(1):6-14.
2008: Markus Waldecker; Tanja Kautenburger; Heike Daumann; Selveraju Veeriah; Frank Will; Helmut Dietrich; Beatrice L Pool-Zobel; Dieter Schrenk
Histone-deacetylase inhibition and butyrate formation: Fecal slurry incubations with apple pectin and apple juice extracts.
Nutrition (Burbank, Los Angeles County, Calif.) 2008;24(4):366-74.
2008: Leo T M van der Ven; Ton van de Kuil; Aart Verhoef; P E G Leonards; Wout Slob; Rocío F Cantón; Silke Germer; Timo Hamers; Theo J Visser; Sabina Litens; Helen Håkansson; Yvonne Fery; Dieter Schrenk; Martin van den Berg; Aldert H Piersma; Joseph G Vos
A 28-day oral dose toxicity study enhanced to detect endocrine effects of a purified technical pentabromodiphenyl ether (pentaBDE) mixture in Wistar rats.
Toxicology 2008;245(1-2):109-22.
2007: Sofia Berggren; Christine Gall; Nadine Wollnitz; Mats Ekelund; Urban Karlbom; Janet Hoogstraate; Dieter Schrenk; Hans Lennernäs
Gene and protein expression of P-glycoprotein, MRP1, MRP2, and CYP3A4 in the small and large human intestine.
Molecular pharmaceutics 2007;4(2):252-7.
2006: Christine Pohl; Frank Will; Helmut Dietrich; Dieter Schrenk
Cytochrome P450 1A1 expression and activity in Caco-2 cells: modulation by apple juice extract and certain apple polyphenols.
Journal of agricultural and food chemistry 2006;54(26):10262-8.
2006: Stefanie Knerr; Dieter Schrenk
Carcinogenicity of "non-dioxinlike" polychlorinated biphenyls.
Critical reviews in toxicology 2006;36(9):663-94.
2006: Stefanie Knerr; Dieter Schrenk
Carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin in experimental models.
Molecular nutrition & food research 2006;50(10):897-907.
2006: Susanne Kunz; Michael Schwarz; Bernd Schilling; Olaf Päpke; Hans-Joachim Lehmler; Larry W Robertson; Dieter Schrenk; Hans-Joachim Schmitz
Tumor promoting potency of PCBs 28 and 101 in rat liver.
Toxicology letters 2006;164(2):133-43.
2006: Stefanie Knerr; Johanna Schaefer; Saskia Both; Angela Mally; Wolfgang Dekant; Dieter Schrenk
2,3,7,8-Tetrachlorodibenzo-p-dioxin induced cytochrome P450s alter the formation of reactive oxygen species in liver cells.
Molecular nutrition & food research 2006;50(4-5):378-84.
2006: Silke Germer; Aldert H Piersma; Leo T M van der Ven; Andreas Kamyschnikow; Yvonne Fery; Hans-Joachim Schmitz; Dieter Schrenk
Subacute effects of the brominated flame retardants hexabromocyclododecane and tetrabromobisphenol A on hepatic cytochrome P450 levels in rats.
Toxicology 2006;218(2-3):229-36.
2005: Annette Baumgart; Melanie Schmidt; Hans-Joachim Schmitz; Dieter Schrenk
Natural furocoumarins as inducers and inhibitors of cytochrome P450 1A1 in rat hepatocytes.
Biochemical pharmacology 2005;69(4):657-67.
2005: M Schmidt; Hans-Joachim Schmitz; Annette Baumgart; D Guédon; MI Netsch; M-H Kreuter; CB Schmidlin; Dieter Schrenk
Toxicity of green tea extracts and their constituents in rat hepatocytes in primary culture.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 2005;43(2):307-14.
2004: Dieter Schrenk
[Chemical food contaminants].
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2004;47(9):841-7.
2004: Dieter Schrenk; Hans-Joachim Schmitz; S Bohnenberger; B Wagner; W Wörner
Tumor promoters as inhibitors of apoptosis in rat hepatocytes.
Toxicology letters 2004;149(1-3):43-50.
2004: Judith Racky; Hans-Joachim Schmitz; Hans-Martin Kauffmann; Dieter Schrenk
Single nucleotide polymorphism analysis and functional characterization of the human Ah receptor (AhR) gene promoter.
Archives of biochemistry and biophysics 2004;421(1):91-8.
2002: Silke Conrad; Hans-Martin Kauffmann; Ken-ichi Ito; Elaine M Leslie; Roger G Deeley; Dieter Schrenk; SUSAN COLE
A naturally occurring mutation in MRP1 results in a selective decrease in organic anion transport and in increased doxorubicin resistance.
Pharmacogenetics 2002;12(4):321-30.
2002: Hans-Martin Kauffmann; Sylvia Pfannschmidt; Heike Zöller; Anke Benz; Birgit Vorderstemann; Jeanette Webster Marketon; Dieter Schrenk
Influence of redox-active compounds and PXR-activators on human MRP1 and MRP2 gene expression.
Toxicology 2002;171(2-3):137-46.
2002: Dieter Schrenk
Regulatory toxicology: objectives and tasks defined by the working group of the German society of experimental and clinical pharmacology and toxicology.
Toxicology letters 2002;126(3):167.
2002: Julia Scheel; Ragna Hussong; Dieter Schrenk; Hans-Joachim Schmitz
Variability of the human aryl hydrocarbon receptor nuclear translocator (ARNT) gene.
Journal of human genetics 2002;47(5):217-24.
2001: Hans-Martin Kauffmann; Birgit Vorderstemann; Dieter Schrenk
Basal expression of the rat, but not of the human, multidrug resistance protein 2 (MRP2) gene is mediated by CBF/NF-Y and Sp1 promoter-binding sites.
Toxicology 2001;167(1):25-35.
2001: S Bohnenberger; B Wagner; Hans-Joachim Schmitz; Dieter Schrenk
Inhibition of apoptosis in rat hepatocytes treated with 'non-dioxin-like' polychlorinated biphenyls.
Carcinogenesis 2001;22(10):1601-6.
2001: M Zeiger; R Haag; J Höckel; Dieter Schrenk; Hans-Joachim Schmitz
Inducing effects of dioxin-like polychlorinated biphenyls on CYP1A in the human hepatoblastoma cell line HepG2, the rat hepatoma cell line H4IIE, and rat primary hepatocytes: comparison of relative potencies.
Toxicological sciences : an official journal of the Society of Toxicology 2001;63(1):65-73.
2001: G Wille; Peter Mayser; Wiebke Thoma; Thomas K Monsees; Annette Baumgart; Hans-Joachim Schmitz; Dieter Schrenk; Kurt Polborn; Wolfgang Steglich
Malassezin--A novel agonist of the arylhydrocarbon receptor from the yeast Malassezia furfur.
Bioorganic & medicinal chemistry 2001;9(4):955-60.
2001: Dieter Schrenk; P R Baus; N Ermel; C Klein; Birgit Vorderstemann; Hans-Martin Kauffmann
Up-regulation of transporters of the MRP family by drugs and toxins.
Toxicology letters 2001;120(1-3):51-7.
2001: Silke Conrad; A Viertelhaus; A Orzechowski; Janet Hoogstraate; K Gjellan; Dieter Schrenk; Hans-Martin Kauffmann
Sequencing and tissue distribution of the canine MRP2 gene compared with MRP1 and MDR1.
Toxicology 2001;156(2-3):81-91.
2001: Silke Conrad; Hans-Martin Kauffmann; K Ito; Roger G Deeley; SUSAN COLE; Dieter Schrenk
Identification of human multidrug resistance protein 1 (MRP1) mutations and characterization of a G671V substitution.
Journal of human genetics 2001;46(11):656-63.
2001: A Eneroth; E Aström; Janet Hoogstraate; Dieter Schrenk; S Conrad; Hans-Martin Kauffmann; K Gjellan
Evaluation of a vincristine resistant Caco-2 cell line for use in a calcein AM extrusion screening assay for P-glycoprotein interaction.
European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 2001;12(3):205-14.
2000: Martin F Fromm; Hans-Martin Kauffmann; P Fritz; Oliver Burk; Heyo K Kroemer; Rolf Warzok; Michel Eichelbaum; Werner Siegmund; Dieter Schrenk
The effect of rifampin treatment on intestinal expression of human MRP transporters.
The American journal of pathology 2000;157(5):1575-80.
2000: J Scheel; Dieter Schrenk
Genomic structure of the human Ah receptor nuclear translocator gene (hARNT).
Human genetics 2000;107(4):397-9.
2000: K Westphal; Anita Weinbrenner; Michael Zschiesche; Gerd Franke; M Knoke; Reinhard Oertel; P Fritz; Oliver Von Richter; Rolf Warzok; Thomas Hachenberg; Hans-Martin Kauffmann; Dieter Schrenk; Bernd Terhaag; Heyo K Kroemer; Werner Siegmund
Induction of P-glycoprotein by rifampin increases intestinal secretion of talinolol in human beings: a new type of drug/drug interaction.
Clinical pharmacology and therapeutics 2000;68(4):345-55.
1999: M Till; D Riebniger; Hans-Joachim Schmitz; Dieter Schrenk
Potency of various polycyclic aromatic hydrocarbons as inducers of CYP1A1 in rat hepatocyte cultures.
Chemico-biological interactions 1999;117(2):135-50.
1999: Dieter Schrenk; D Riebniger; M Till; S Vetter; Hans-Peter Fiedler
Tryptanthrins and other tryptophan-derived agonists of the dioxin receptor.
Advances in experimental medicine and biology 1999;467():403-8.
1998: W Wörner; Dieter Schrenk
2,3,7,8-Tetrachlorodibenzo-p-dioxin suppresses apoptosis and leads to hyperphosphorylation of p53 in rat hepatocytes.
Environmental toxicology and pharmacology 1998;6(4):239-47.
1998: Hans-Martin Kauffmann; Dietrich Keppler; T W Gant; Dieter Schrenk
Induction of hepatic mrp2 (cmrp/cmoat) gene expression in nonhuman primates treated with rifampicin or tamoxifen.
Archives of toxicology 1998;72(12):763-8.
1998: D Riebniger; Dieter Schrenk
Nonresponsiveness to 2,3,7,8-tetrachlorodibenzo-p-dioxin of transforming growth factor beta1 and CYP 1A1 gene expression in rat liver fat-storing cells.
Toxicology and applied pharmacology 1998;152(1):251-60.
1998: R Weber; Hanspaul Hagenmaier; Dieter Schrenk
Elimination kinetics and toxicity of 2,3,7,8-tetrachlorothianthren, a thio analogue of 2,3,7,8-TCDD.
Chemosphere 1998;36(12):2635-41.
1998: Hans-Martin Kauffmann; Dieter Schrenk
Sequence analysis and functional characterization of the 5'-flanking region of the rat multidrug resistance protein 2 (mrp2) gene.
Biochemical and biophysical research communications 1998;245(2):325-31.
1998: Dieter Schrenk
Impact of dioxin-type induction of drug-metabolizing enzymes on the metabolism of endo- and xenobiotics.
Biochemical pharmacology 1998;55(8):1155-62.
1998: Dieter Schrenk; D Brockmeier; Klaus Mörike; Karl Walter Bock; Michel Eichelbaum
A distribution study of CYP1A2 phenotypes among smokers and non-smokers in a cohort of healthy Caucasian volunteers.
European journal of clinical pharmacology 1998;53(5):361-7.
1997: M Till; PA Behnisch; Hanspaul Hagenmaier; Karl Walter Bock; Dieter Schrenk
Dioxinlike components in incinerator fly ash: a comparison between chemical analysis data and results from a cell culture bioassay.
Environmental health perspectives 1997;105(12):1326-32.
1997: Hans-Martin Kauffmann; Dietrich Keppler; Jürgen Kartenbeck; Dieter Schrenk
Induction of cMrp/cMoat gene expression by cisplatin, 2-acetylaminofluorene, or cycloheximide in rat hepatocytes.
Hepatology (Baltimore, Md.) 1997;26(4):980-5.
1997: Dieter Schrenk; D Riebniger; M Till; S Vetter; Hans-Peter Fiedler
Tryptanthrins: a novel class of agonists of the aryl hydrocarbon receptor.
Biochemical pharmacology 1997;54(1):165-71.
1997: Hans-Joachim Schmitz; A Hagenmaier; Hanspaul Hagenmaier; L Poellinger; R Weber; Dieter Schrenk
2,3,7,8-Tetrafluorodibenzo-p-dioxin: a potent agonist of the murine dioxin receptor.
Environmental toxicology and pharmacology 1997;3(2):105-13.
1997: Dieter Schrenk; M Müller; G Merlino; S S Thorgeirsson
Interactions of TCDD with signal transduction and neoplastic development in c-myc transgenic and TGF-alpha transgenic mice.
Archives of toxicology. Supplement. = Archiv für Toxikologie. Supplement 1997;19():367-75.
1997: R Weber; Hans-Joachim Schmitz; Dieter Schrenk; Hanspaul Hagenmaier
Metabolic degradation, inducing potency, and metabolites of fluorinated and chlorinated-fluorinated dibenzodioxins and dibenzofurans.
Chemosphere 1997;34(1):29-40.
1996: Dieter Schrenk; A Orzechowski; L R Schwarz; R Snyder; B Burchell; M Ingelman-Sundberg; Karl Walter Bock
Phase II metabolism of benzene.
Environmental health perspectives 1996;104 Suppl 6():1183-8.
1996: Dieter Schrenk; A Michalke; T W Gant; P C Brown; J A Silverman; Snorri S Thorgeirsson
Multidrug resistance gene expression in rodents and rodent hepatocytes treated with mitoxantrone.
Biochemical pharmacology 1996;52(9):1453-60.
1996: W Worner; Dieter Schrenk
Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor beta 1.
Cancer research 1996;56(6):1272-8.
1996: G Gohl; T Lehmköster; Peter A Münzel; Dieter Schrenk; Richard Viebahn; Karl Walter Bock
TCDD-inducible plasminogen activator inhibitor type 2 (PAI-2) in human hepatocytes, HepG2 and monocytic U937 cells.
Carcinogenesis 1996;17(3):443-9.
1996: Hans-Joachim Schmitz; PA Behnisch; Karl Walter Bock; A Hagenmaier; Hanspaul Hagenmaier; Dieter Schrenk
CYP1A1-inducing potency in H4IIE cells and chemical composition of technical mixtures of polychlorinated biphenyls.
Environmental toxicology and pharmacology 1996;1(1):73-9.
1995: A Orzechowski; L R Schwarz; U Schwegler; Karl Walter Bock; R Snyder; Dieter Schrenk
Benzene metabolism in rodent hepatocytes: role of sulphate conjugation.
Xenobiotica; the fate of foreign compounds in biological systems 1995;25(10):1093-102.
1995: Hans-Joachim Schmitz; A Hagenmaier; Hanspaul Hagenmaier; Karl Walter Bock; Dieter Schrenk
Potency of mixtures of polychlorinated biphenyls as inducers of dioxin receptor-regulated CYP1A activity in rat hepatocytes and H4IIE cells.
Toxicology 1995;99(1-2):47-54.
1995: Dieter Schrenk; T Stüven; G Gohl; Richard Viebahn; Karl Walter Bock
Induction of CYP1A and glutathione S-transferase activities by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human hepatocyte cultures.
Carcinogenesis 1995;16(4):943-6.
1995: R Weber; Dieter Schrenk; Hans-Joachim Schmitz; A Hagenmaier; Hanspaul Hagenmaier
Polyfluorinated dibenzodioxins and dibenzofurans--synthesis, analysis, formation and toxicology.
Chemosphere 1995;30(4):629-39.
1995: J Buchthal; KE Grund; Albrecht Buchmann; Dieter Schrenk; P Beaune; Karl Walter Bock
Induction of cytochrome P4501A by smoking or omeprazole in comparison with UDP-glucuronosyltransferase in biopsies of human duodenal mucosa.
European journal of clinical pharmacology 1995;47(5):431-5.
1994: Dieter Schrenk; T W Gant; A Michalke; A Orzechowski; J A Silverman; N Battula; Snorri S Thorgeirsson
Metabolic activation of 2-acetylaminofluorene is required for induction of multidrug resistance gene expression in rat liver cells.
Carcinogenesis 1994;15(11):2541-6.
1994: T W Gant; Dieter Schrenk; J A Silverman; Snorri S Thorgeirsson
Requirement for metabolic activation of acetylaminofluorene to induce multidrug gene expression.
Environmental health perspectives 1994;102 Suppl 6():209-12.
1994: A Orzechowski; Dieter Schrenk; Barbara S Bock-Hennig; Karl Walter Bock
Glucuronidation of carcinogenic arylamines and their N-hydroxy derivatives by rat and human phenol UDP-glucuronosyltransferase of the UGT1 gene complex.
Carcinogenesis 1994;15(8):1549-53.
1994: Karl Walter Bock; Dieter Schrenk; A Forster; Ernst-Ulrich Griese; Klaus Mörike; D Brockmeier; Michel Eichelbaum
The influence of environmental and genetic factors on CYP2D6, CYP1A2 and UDP-glucuronosyltransferases in man using sparteine, caffeine, and paracetamol as probes.
Pharmacogenetics 1994;4(4):209-18.
1994: Dieter Schrenk; Albrecht Buchmann; K Dietz; H P Lipp; H Brunner; H Sirma; Peter A Münzel; Hanspaul Hagenmaier; Rolf Gebhardt; Karl Walter Bock
Promotion of preneoplastic foci in rat liver with 2,3,7,8-tetrachlorodibenzo-p-dioxin, 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin and a defined mixture of 49 polychlorinated dibenzo-p-dioxins.
Carcinogenesis 1994;15(3):509-15.
1994: A Orzechowski; Dieter Schrenk; H A Schut; Karl Walter Bock
Consequences of 3-methylcholanthrene-type induction for the metabolism of 4-aminobiphenyl in isolated rat hepatocytes.
Carcinogenesis 1994;15(3):489-94.
1994: Dieter Schrenk; S Schäfer; Karl Walter Bock
2,3,7,8-Tetrachlorodibenzo-p-dioxin as growth modulator in mouse hepatocytes with high and low affinity Ah receptor.
Carcinogenesis 1994;15(1):27-31.
1993: Dieter Schrenk; T W Gant; K H Preisegger; J A Silverman; P A Marino; Snorri S Thorgeirsson
Induction of multidrug resistance gene expression during cholestasis in rats and nonhuman primates.
Hepatology (Baltimore, Md.) 1993;17(5):854-60.
1992: A Orzechowski; Dieter Schrenk; Karl Walter Bock
Metabolism of 1- and 2-naphthylamine in isolated rat hepatocytes.
Carcinogenesis 1992;13(12):2227-32.
1992: Dieter Schrenk; A Karger; H P Lipp; Karl Walter Bock
2,3,7,8-Tetrachlorodibenzo-p-dioxin and ethinylestradiol as co-mitogens in cultured rat hepatocytes.
Carcinogenesis 1992;13(3):453-6.
1992: Dieter Schrenk; M Ingelman-Sundberg; Karl Walter Bock
Influence of P-4502E1 induction on benzene metabolism in rat hepatocytes and on biliary metabolite excretion.
Drug metabolism and disposition: the biological fate of chemicals 1992;20(2):137-41.
1992: H P Lipp; Dieter Schrenk; T Wiesmüller; Hanspaul Hagenmaier; Karl Walter Bock
Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins (PCDDs) and their constituents in human HepG2 cells.
Archives of toxicology 1992;66(3):220-3.
1991: A B Kobusch; Dieter Schrenk; G Gans; Peter A Münzel; J Werringloer; M Ingelman-Sundberg; Karl Walter Bock
Immunochemical localization and functional characterization of cytochrome P450IIE1 in rat hepatocyte foci and nodules.
Carcinogenesis 1991;12(12):2353-6.
1991: Dieter Schrenk; I Eisenmann-Tappe; Rolf Gebhardt; D Mayer; M el Mouelhi; E Röhrdanz; Peter A Münzel; Karl Walter Bock
Drug metabolizing enzyme activities in rat liver epithelial cell lines, hepatocytes and bile duct cells.
Biochemical pharmacology 1991;41(11):1751-7.
1991: Dieter Schrenk; H P Lipp; T Wiesmüller; Hanspaul Hagenmaier; Karl Walter Bock
Assessment of biological activities of mixtures of polychlorinated dibenzo-p-dioxins: comparison between defined mixtures and their constituents.
Archives of toxicology 1991;65(2):114-8.
1990: Dieter Schrenk; Karl Walter Bock
Metabolism of benzene in rat hepatocytes. Influence of inducers on phenol glucuronidation.
Drug metabolism and disposition: the biological fate of chemicals 1990;18(5):720-5.
1990: Karl Walter Bock; Peter A Münzel; E Röhrdanz; Dieter Schrenk; L C Eriksson
Persistently increased expression of a 3-methylcholanthrene-inducible phenol uridine diphosphate-glucuronosyltransferase in rat hepatocyte nodules and hepatocellular carcinomas.
Cancer research 1990;50(12):3569-73.
1985: M Schwarz; Albrecht Buchmann; H Klormann; Dieter Schrenk; W Kunz
Effect of phenobarbital and other liver monooxygenase modifiers on dimethylnitrosamine-induced alkylation of rat liver macromolecules.
Cancer research 1985;45(5):2020-4.